Epstein-Barr Virus Induces Erosive Arthritis in Humanized Mice

Epstein-Barr virus (EBV) has been implicated in the pathogenesis of rheumatoid arthritis (RA) on the basis of indirect evidence, such as its presence in affected joint tissues, antigenic cross reactions between EBV and human proteins, and elevated humoral and cellular anti-EBV immune responses in patients. Here we report development of erosive arthritis closely resembling RA in humanized mice inoculated with EBV. Human immune system components were reconstituted in mice of the NOD/Shi-scid/IL-2Rγnull (NOG) strain by transplantation with CD34+ hematopoietic stem cells isolated from cord blood. These humanized mice were then inoculated with EBV and examined pathologically for the signs of arthritis. Erosive arthritis accompanied by synovial membrane proliferation, pannus formation, and bone marrow edema developed in fifteen of twenty-three NOG mice transplanted with human HSC and inoculated with EBV, but not in the nine NOG mice that were transplanted with HSC but not inoculated with EBV. This is the first report of an animal model of EBV-induced arthritis and strongly suggest a causative role of the virus in RA.

[1]  A. Snow,et al.  X-linked lymphoproliferative syndromes: brothers or distant cousins? , 2010, Blood.

[2]  Mamoru Ito,et al.  T cell-mediated control of Epstein-Barr virus infection in humanized mice. , 2009, The Journal of infectious diseases.

[3]  Mamoru Ito,et al.  A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. , 2008, The Journal of infectious diseases.

[4]  J. Lünemann,et al.  Increased Frequency of EBV-Specific Effector Memory CD8+ T Cells Correlates with Higher Viral Load in Rheumatoid Arthritis1 , 2008, The Journal of Immunology.

[5]  Mamoru Ito,et al.  Humanized NOD/SCID/IL2Rγnull Mice Transplanted with Hematopoietic Stem Cells under Nonmyeloablative Conditions Show Prolonged Life Spans and Allow Detailed Analysis of Human Immunodeficiency Virus Type 1 Pathogenesis , 2007, Journal of Virology.

[6]  T. Morio,et al.  Hematopoietic stem cell–engrafted NOD/SCID/IL2Rγnull mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses , 2007 .

[7]  T. Morio,et al.  Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. , 2007, Blood.

[8]  Nathalie Balandraud,et al.  Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. , 2003, Arthritis and rheumatism.

[9]  M. Takei,et al.  Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis. , 2001, International immunology.

[10]  T. Morishima,et al.  Quantitative Analysis of Epstein-Barr Virus Load by Using a Real-Time PCR Assay , 1999, Journal of Clinical Microbiology.

[11]  M. Takei,et al.  Detection of Epstein-Barr virus-encoded small RNA 1 and latent membrane protein 1 in synovial lining cells from rheumatoid arthritis patients. , 1997, International immunology.

[12]  M. Bonneville,et al.  T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis , 1996, The Journal of experimental medicine.

[13]  J. Roudier,et al.  Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Roudier,et al.  The Epstein‐Barr Virus Glycoprotein gp110, a Molecular Link between HLA DR4, HLA DR1, and Rheumatoid Arthritis , 1988, Scandinavian journal of immunology.

[15]  D. Carson,et al.  The glycine-alanine repeating region is the major epitope of the Epstein-Barr nuclear antigen-1 (EBNA-1). , 1987, Journal of immunology.

[16]  G. Rhodes,et al.  Rheumatoid arthritis synovial membrane contains a 62,000-molecular-weight protein that shares an antigenic epitope with the Epstein-Barr virus-encoded associated nuclear antigen. , 1986, The Journal of clinical investigation.

[17]  R. Houghten,et al.  Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen. , 1985, Journal of immunology.

[18]  A. Steinberg,et al.  Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. , 1984, The Journal of clinical investigation.

[19]  D. Carson,et al.  Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Steinberg,et al.  Defective EBV-specific suppressor T-cell function in rheumatoid arthritis. , 1981, The New England journal of medicine.

[21]  F. Jensen,et al.  Lymphocytes transformed by Epstein-Barr virus. Induction of nuclear antigen reactive with antibody in rheumatoid arthritis , 1978, The Journal of experimental medicine.